₹ 1655.1
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental,...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive'
Target Price
The average target price of SUNPHARMA.NS is 1951 and suggests 18% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t
